Impaired Proinflammatory Response in Stringently Defined Otitis-prone Children During Viral Upper Respiratory

Dabin Ren1, Qingfu Xu1, Anthony L Almudevar2

  • 1Rochester General Hospital Research Institute, University of Rochester Medical Center, New York.

Insights

Stringently-defined otitis-prone (sOP) children experience more viral upper respiratory infections (URIs) and acute otitis media (AOM) due to deficient nasopharyngeal inflammatory responses. This suggests a link between impaired antiviral immunity and recurrent ear infections in susceptible children.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Otolaryngology

Background:

  • Viral upper respiratory infections (URIs) commonly precede bacterial acute otitis media (AOM) in young children.
  • Acute inflammatory responses during viral URIs are crucial for preventing AOM development.
  • Stringently-defined otitis-prone (sOP) children are highly susceptible to recurrent AOM.

Purpose of the Study:

  • To assess nasopharyngeal proinflammatory cytokine and chemokine levels during viral URIs.
  • To compare nasopharyngeal inflammatory responses between viral URI events and subsequent AOM episodes.
  • To differentiate these responses between sOP and non-otitis-prone (NOP) children.

Main Methods:

  • Nasopharyngeal samples were collected during viral URIs and AOM episodes in sOP and NOP children.
  • Levels of various proinflammatory cytokines and chemokines were measured.
  • Statistical analysis compared inflammatory profiles between groups and conditions.

Main Results:

  • sOP children had significantly more AOM episodes, viral URIs, and viral URIs followed by AOM compared to NOP children.
  • sOP children exhibited lower nasopharyngeal levels of IL-6, IL-10, TNF-α, and RANTES during viral URIs.
  • NOP children showed distinct inflammatory profiles during URIs versus AOM, with higher levels of multiple cytokines/chemokines compared to sOP children.

Conclusions:

  • sOP children experience more frequent viral URIs and AOM.
  • This increased susceptibility is attributed to deficient antiviral nasopharyngeal proinflammatory cytokine and chemokine responses.
  • Impaired inflammatory responses in sOP children may underlie their predisposition to recurrent AOM.
Abstract

Related Concept Videos

Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
356
Anatomy of Respiratory System I: Upper Respiratory Tract01:29

Anatomy of Respiratory System I: Upper Respiratory Tract

The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features.
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract....
5.3K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
929
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.3K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
670
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.1K